Pharma Cash to Congress
A Ñî¹óåú´«Ã½Ò•îl Health News database tracks campaign donations from drugmakers over the past 10 years.
The independent source for health policy research, polling, and news.
Elizabeth Lucas was the data editor at Ñî¹óåú´«Ã½Ò•îl Health News until August 2021.
Showing 1 - 20 of 32
A Ñî¹óåú´«Ã½Ò•îl Health News database tracks campaign donations from drugmakers over the past 10 years.
With an eye to shutting down Medicare drug price negotiations, drug companies and their lobbying groups gave roughly $1.6 million in the first six months of 2021, with Democrats edging closer than they have in a decade to Republicans’ total haul.
In Texas’ border communities, which are overwhelmingly Hispanic, covid-19 death rates for people under age 65 were double those in the rest of the state and three times the national average. They were also significantly higher than rates in New Mexico border areas.
Federal officials say that some of the money changing hands has corrupted doctors and endangered patients.
Sen. Kyrsten Sinema has received almost $100,000 from drug companies in the current election cycle, a KHN analysis shows, one of the largest cash hauls in Congress. And it’s only her first term.
In 470,000 American homes spread across every state, washing hands to prevent COVID-19 may not be as easy as turning on a faucet. They don’t have showers or toilets or, in some cases, even water piped into their homes. Nearly a million U.S. homes don’t have complete kitchens and millions more are overcrowded, making it much tougher for people to shelter in place and avoid infection.
In the first round of emergency relief, some states will get more than $300,000 per COVID-19 patient, while hard-hit New York gets just $12,000 per patient.
A Kaiser Health News analysis shows that counties with ICUs average one ICU bed for every 1,300 older residents, those most at risk for needing hospitalization.
More nursing homes have been faulted for failing to follow practices designed to prevent and control infections than for any other type of error. Such lapses have become matters of heightened concern with the spread of the coronavirus this spring, especially as the virus is a bigger threat to the elderly.
The bold move by the giant hospital system will help thousands of patients in the wake of a Kaiser Health News investigation last year.
A letter from the Senate Finance Committee chairman questions the University of Virginia Health System about its financial assistance policies, billing practices and prices.
Patients at VCU Health will no longer be taken to court and can more easily get financial assistance to pay their bills.
But critics say the new policy still leaves some patients exposed to lawsuits and crippling bills.
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
A Kaiser Health News investigation, which first appeared in The Washington Post, showed that the University of Virginia Health System has sued patients 36,000 times for more than $106 million.
Over six years, the state institution filed 36,000 lawsuits against patients seeking a total of more than $106 million in unpaid bills, a KHN analysis finds.
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
Research out Wednesday indicates that guidelines are making strides in cutting back the number of pain pills doctors offer after specific types of surgeries.
A new data analysis by KHN and Johns Hopkins researchers shows that even as the CDC issued warnings, surgeons handed out many times the number of opioid pills needed for post-op pain.
Even as awareness of the opioid crisis grew, prescribing habits of surgeons changed very little from 2011 to 2016, found a data analysis by KHN and Johns Hopkins Bloomberg School of Public Health. Use this interactive tool to search by doctor or practicing hospital.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF